Mission statement · Company scope
“Our mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche immune-compromised patient populations.”
In use2017 – now1 sighting
First seenFeb 2017Added
Last seenFeb 2017Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary)
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 17 words · reading grade 17.9
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.76
- Record
- st_90041561a62d6b30
- Classification confidence
- 0.85
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2017-02-24 · sec_sentence · 10-K · accession 0001193805-17-000330
View filing ↗0 to compareCompare